Advancis is a pharmaceutical company focused on developing and commercializing novel anti-infective products.
Business Model:
Revenue: $0
Employees: 51-500
Address:
City: Germantown
State: Maryland
Zip:
Country: United States
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/13/2003
Ticker Symbol:
MBRK
Amount Raised:
$60M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2012 | Boston Therapeutics | Post-IPO Equity | 0 |
6/2012 | Boston Therapeutics | Post-IPO Equity | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2008 | Post-IPO Equity | 2 | $21M |
HealthCare Ventures Rho Ventures HealthCare Ventures Rho Ventures |
7/2008 | Post-IPO Equity | 1 | $100M |
Equity Group Investments Equity Group Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|